Leavell Investment Management Inc. Decreases Stake in Danaher Corporation $DHR

Leavell Investment Management Inc. cut its position in shares of Danaher Corporation (NYSE:DHR) by 11.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,217 shares of the conglomerate’s stock after selling 1,047 shares during the period. Leavell Investment Management Inc.’s holdings in Danaher were worth $1,626,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. increased its position in Danaher by 0.4% in the first quarter. Vanguard Group Inc. now owns 59,981,088 shares of the conglomerate’s stock worth $12,296,123,000 after purchasing an additional 230,966 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Danaher by 3.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 19,592,211 shares of the conglomerate’s stock worth $4,016,404,000 after buying an additional 612,154 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Danaher by 2.3% in the 1st quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate’s stock worth $1,800,614,000 after buying an additional 194,466 shares during the last quarter. Invesco Ltd. raised its position in shares of Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock valued at $965,259,000 after buying an additional 1,450,703 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Danaher by 4.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,230,087 shares of the conglomerate’s stock valued at $867,168,000 after acquiring an additional 163,332 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

Shares of NYSE:DHR opened at $223.03 on Friday. The firm’s 50 day simple moving average is $202.73 and its 200-day simple moving average is $198.53. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.22 and a current ratio of 1.52. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The firm has a market cap of $157.54 billion, a PE ratio of 45.99, a price-to-earnings-growth ratio of 3.41 and a beta of 0.77.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is presently 26.39%.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research note on Thursday. Barclays increased their price target on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday. Redburn Partners set a $220.00 price objective on shares of Danaher in a research note on Wednesday, October 8th. Guggenheim restated a “buy” rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Finally, TD Cowen upped their price target on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.